Biogen (BIIB) PT Raised to $360 at Piper Sandler into Zuranolone PDUFA
Tweet Send to a Friend
(Updated - June 1, 2023 8:56 AM EDT)
Piper Sandler analyst Christopher Raymond raised the price target on Biogen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Christopher Raymond raised the price target on Biogen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
